High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1
Anne Steins(Oncode Institute), Maarten F. Bijlsma(Dutch Cancer Society)
Cited by 39
Related Papers
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597
Molecular subtyping of cancer: current status and moving toward clinical applications
|Briefings in Bioinformatics|2018|150
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues
|Molecular Oncology|2024|9
Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinoma
|Pharmacological Research|2024|4
Estrogen Production in Pancreatic Cancer Shapes a Tumor-Suppressive Stromal Microenvironment
|Cancer Research|2025|0